Related Experiment Videos
Distinguishing between response to HIV vaccine and response to HIV
1Department of Communicable Diseases and Ganitourinary Medicine, Imperial College School of Medicine, St Mary's, London, UK.
Lancet (London, England)
|July 26, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
alpha-Aspartate 261 is a key residue in noncatalytic sites of Escherichia coli F1-ATPase.
The Journal of biological chemistry·1995
P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site.
The Journal of biological chemistry·1995
Effects of the German 1993 health reform law upon primary care practitioners' individual performance: results from an empirical study in sentinel practices.
Journal of epidemiology and community health·1995
Gene-based sequence-tagged-sites (STSs) as the basis for a human gene map.
Nature genetics·1995
HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.
BMJ (Clinical research ed.)·1995
Increase of skeletal muscle relaxation speed by direct injection of parvalbumin cDNA.
Proceedings of the National Academy of Sciences of the United States of America·1995
Wildfire smoke and health: current evidence, mechanisms, and future challenges.
Lancet (London, England)·2026
KDM6B inhibition modulates monocyte activation and alleviates IMQ-induced psoriasis-like skin inflammation.
Cell communication and signaling : CCS·2026
Assessing persistent antitumor immunity induced by tumor derived extracellular vesicle hydrogel vaccination without neoantigen identification.
International immunopharmacology·2026